Sign up to save your podcasts
Or
Share Drugmakers Face Ongoing Vaccine Hesitancy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Drugmakers Face Ongoing Vaccine Hesitancy
P.M. Edition for May 31. The FDA approves Pfizer’s vaccine for RSV, a deadly respiratory virus. But as Wall Street Journal health business editor Jonathan Rockoff reports, companies are preparing to introduce the shots after resistance to vaccination reached new highs during the pandemic. Annmarie Fertoli hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By The Wall Street Journal
4.1
39513,951 ratings
P.M. Edition for May 31. The FDA approves Pfizer’s vaccine for RSV, a deadly respiratory virus. But as Wall Street Journal health business editor Jonathan Rockoff reports, companies are preparing to introduce the shots after resistance to vaccination reached new highs during the pandemic. Annmarie Fertoli hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like WSJ What’s News
View all
WSJ Tech News Briefing
1,630 Listeners
WSJ Your Money Briefing
1,748 Listeners
Bloomberg Businessweek
443 Listeners
Goldman Sachs Exchanges
988 Listeners
WSJ Opinion: Potomac Watch
2,794 Listeners
WSJ Minute Briefing
656 Listeners
Bold Names
1,450 Listeners
Wall Street Breakfast
1,010 Listeners
Thoughts on the Market
1,275 Listeners
The Journal.
5,893 Listeners
Barron's Streetwise
1,526 Listeners
Barron's Live
190 Listeners
Bad Bets
1,317 Listeners
WSJ Opinion: Free Expression
571 Listeners
As We Work
151 Listeners
Bloomberg Daybreak: US Edition
48 Listeners
WSJ's Take On the Week
124 Listeners